The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Biphozyl Solution for haemodialysis / haemofiltration



Baxter Holding B.V.PA2299/055/001

Main Information

Trade NameBiphozyl Solution for haemodialysis / haemofiltration
Active SubstancesDisodium phosphate dihydrate
Magnesium chloride hexahydrate
Sodium hydrogen carbonate
Sodium chloride
Potassium chloride
Dosage FormSolution for haemodialysis/haemofiltration
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/055/001

Group Information

ATC CodeB05ZB Hemofiltrates

Status

License statusAuthorised
Licence Issued28/11/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back